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Vascular endothelial growth factor (VEGF) is an angiogenic factor and a potent stimulator of microvascular permeability.
It is a mitogen specific for endothelial cells. The expression of VEGF and its two receptors, Flk-1 and Flt-1, is pivotal for the
proper formation of blood vessels in embryogenesis as shown by gene-targeting experiments. Interestingly, the loss of even
a single allele of VEGF led to embryonic lethality between day E9.5 and day E10.5 in the mouse. To assess the role of VEGF
during embryonic development we decided to tag VEGF expression with LacZ, by inserting an IRES (internal ribosome entry
site)–LacZ reporter cassette into the 3* untranslated region of the gene. This alteration enabled us to monitor VEGF
xpression throughout embryonic development at single-cell resolution. b-Galactosidase expression from the altered VEGF
ocus was first observed prior to gastrulation and was detectable at all stages of vascular development in the embryo. Later,
he specific cellular distribution and the level of VEGF expression indicated its pleiotropic role in development. High
xpression levels seemed to be associated with vasculogenesis and permeability, whereas lower levels were associated with
ngiogenesis and cell migration. In addition, we found VEGF expression in a subtype of endothelial cells present in the
ndocardium. We believe that the LacZ-tagged allele we have generated offers a precise means of detecting VEGF expression
nder a variety of physiological and pathological conditions. © 1999 Academic Press
Key Words: vascular endothelial growth factor; endothelial cells; gene targeting; IRES-lacZ knock-in; embryonicdevelopment; vasculogenesis; angiogenesis.
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oINTRODUCTION
In all tissues, a functional vasculature is indispensable for
growth, differentiation, and maintenance. During embry-
onic development, blood vessels are initially formed by in
situ differentiation of endothelial precursors (angioblasts),
followed by their assembly into tubes, a mechanism known
as vasculogenesis (Risau and Flamme, 1995). Later in the
embryo and adult, a second mechanism called angiogenesis
also operates when a complex vascular network arises by
sprouting and remodeling of new capillaries from the pre-
existing blood vessels (Risau, 1997). Angiogenesis also plays
a role in blood vessel formation in pathological situations
such as wound healing, retinopathy, and tumor growth
(Folkman and D’Amore, 1996). Endothelial cells play a keye
t
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All rights of reproduction in any form reserved.ole in both of these processes. The differentiation and
roliferation of the endothelium is a complex process
nvolving paracrine signals that act on endothelial cells via
pecific cell surface receptors (Augustin et al., 1994; Risau,
995).
Vascular endothelial growth factor (VEGF) is essential for
ascularization in both physiological and pathological situ-
tions (review in Ferrara and Davis-Smyth, 1997). It was
nitially purified from tumor cells as vascular permeability
actor based on its ability to induce hyperpermeability of
he tumor blood vessels (Senger et al., 1983). VEGF acts as
oth an endothelial cell-specific mitogen (Keck et al., 1989;
eung et al., 1989) and an angiogenic factor (Ploue¨t et al.,
989) and possesses chemoattractant activities for endothe-
ial and nonendothelial cells, including monocytes and
steoclasts (Clauss et al., 1990; Senger et al., 1996; Yoshida
t al., 1996). VEGF is a dimeric glycoprotein that exists in
hree different isoforms of 120, 164, and 188 amino acids
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308 Miquerol et al.produced by alternative splicing of a single gene in the
mouse (Shima et al., 1996). The most abundant isoforms are
VEGF120 and VEGF164. The mitogenic potential of the
EGF164 is higher than that of VEGF120 (Keyt et al., 1996;
Wilting et al., 1996). All VEGF isoforms can bind either of
two receptor tyrosine kinases, VEGFR1 (or Flt-1) or
VEGFR2 (or KDR/Flk-1) (de Vries et al., 1992; Yamaguchi et
l., 1993). Both of these receptors are present on endothelial
ells but the biological activities that they transduce differ.
EGFR2 appears to be the primary receptor that mediates
he mitogenic and chemotactic effects of VEGF on endothe-
ial cells (Clauss et al., 1996; Waltenberger et al., 1994).
mbryos homozygous for the targeted disruption of
EGFR2/Flk-1 die around day E8.5 and fail to form blood
slands and therefore lack mature endothelial and hemato-
oietic cells (Shalaby et al., 1995). The dual activity of Flk-1
n endothelial and hematopoietic cells was confirmed by
himeric analyses in mouse embryos which showed that
EGFR2/Flk-1 is required cell autonomously for endothe-
ial cell differentiation and is also required, but not suffi-
ient, for hematopoietic cell differentiation (Shalaby et al.,
997). VEGFR1/Flt-1 binds VEGF with high affinity; it has
ot been shown to transmit a mitogenic signal, but may be
nvolved in cell migration (Barleon et al., 1996). The impor-
ance of VEGFR1 during embryonic development was dem-
nstrated in gene targeting studies which show that em-
ryos deficient for VEGFR1 die in utero at day E9.5 as a
esult of a disorganized vascular system associated with an
verproduction of endothelial cells (Fong et al., 1995).
EGFR1 signal transduction does not seem to include the
yrosine kinase domain of the receptor since the disruption
f this domain by gene targeting in the mouse does not
ffect normal embryonic development (Hiratsuka et al.,
998).
Recently, Soker et al. reported a third VEGF-receptor,
europilin-1, which binds the VEGF164 isoform and can
otentiate VEGFR2 activity, acting as a coreceptor.
europilin-1 was first identified as a semaphorin/collapsin
eceptor involved in axon guidance (Soker et al., 1998).
verexpression of neuropilin results in cardiovascular de-
ects in embryos, suggesting that the VEGF–neuropilin
omplex may play a role in normal embryonic vascular
evelopment (Kitsukawa et al., 1995).
The role of VEGF during development was investigated
y gene targeting and reveals that the loss of a single allele
s sufficient to impair vascular development. Embryos lack-
ng a single functional VEGF allele die in utero at day E10.5
ue to severe defects in the formation of the dorsal aorta
nd in yolk sac vessels (Carmeliet et al., 1996; Ferrara et al.,
996). Homozygous embryos present an even more severe
henotype, suggesting a tight dose-dependent regulation of
mbryonic vessel development by VEGF (Carmeliet et al.,
996). Moreover, the absence of VEGF in ES cells impaired
umor growth when those cells were injected under the
kin of nude mice (Ferrara et al., 1996).
Copyright © 1999 by Academic Press. All rightThese data indicate that VEGF plays a central role in
ascular development and suggest that VEGF regulation as
ell as its signaling pathways is complex due to the
nterplay of several isoforms and receptors. Thus, the sys-
ematic characterization of the cells that express VEGF will
elp to clarify the complexity of its function. Previous
tudies using RNA in situ hybridization have shown ex-
ression of VEGF during embryonic development at various
tages and in numerous tissues (Breier et al., 1992; Dumont
t al., 1995; Monacci et al., 1993; Peters et al., 1993). This
expression was correlated with the expression of the two
VEGF receptors, VEGFR1 and VEGFR2, in the adjacent
endothelial cells (Dumont et al., 1995; Millauer et al.,
1993), leading to the conclusion that VEGF may have
pleiotropic activities, acting on the proliferation, differen-
tiation, migration, and maturation of endothelial cells. As
in situ hybridization can rarely provide single-cell resolu-
tion and antibodies suitable for immunohistochemistry are
not available or would only detect VEGF bound to its
receptors, we attempted to visualize VEGF expression by
introducing a LacZ reporter gene into the 39 untranslated
region of the endogenous VEGF locus by homologous re-
combination. The use of an internal ribosome entry site
(IRES) in front of LacZ allows independent translation of
both VEGF and the reporter from the same bicistronic
mRNA produced by the targeted allele. This knock-in
strategy provides an accurate readout of VEGF expression at
the cellular level and at the same time circumvents the
lethal haploinsufficiency of the gene.
Here, we report a very intricate regulation of VEGF
throughout the entire process of embryonic development,
including early implantation and late organogenesis. The
complexity of expression points out not only the pivotal
role of this growth factor in endothelial cell proliferation
but also its possible other functions as chemoattractant
and/or survival factor for endothelial and other cell types.
This approach also provides evidence against the generally
accepted view that endothelial cells themselves do not
express VEGF; a certain subtype of endothelial cells, i.e.,
the endocardium, and cells in the outflow tract of the heart
were positive for VEGF. We suggest that this model can be
used to investigate the induction of VEGF expression in
physiopathological conditions in adult mice.
MATERIAL AND METHODS
Construction of the Targeting Vector
Murine genomic clones (strain 129) encompassing exon 4 to
exon 8 of the VEGF gene (Shima et al., 1996) were used to construct
the targeting vector pVEGF-LacZ-KI. The bacterial b-galactosidase
gene (LacZ) was fused to a nuclear localization signal and an IRES
sequence (Jang et al., 1988; Takeuchi et al., 1995). The neomycin
selection marker, flanked by two identically oriented loxP sites
(pLoxPneo) (Takeuchi et al., 1995), was introduced after the LacZ
cassette. The IRES-NLS-LacZ-poly(A)-loxP-neo-loxP cassette was
s of reproduction in any form reserved.
(C
2
a
e
2
m
m
r
p
3
T
t
i
d
s
a
e
1
n
m
i
s
n
w
i
c
t
t
i
t
g
K
t
b
t
309A VEGF LacZ Knock-in Reveals Its Pleiotropic Activitiesligated into the SmaI site located in the 39 untranslated region
UTR) of VEGF 200 bp downstream of the stop codon.
Generation of VEGFLacZ/1 ES Cells and VEGFLacZ
and VEGF LacZDneo Mice
The pVEGF-LacZ-KI vector was linearized using XhoI and elec-
troporated into R1 ES cells as described previously (Nagy et al.,
1993). Genomic DNA prepared from 154 G418-resistant ES cell
clones was digested with BglII and screened by Southern blot using
a 400-bp BglII–EcoRI probe encompassing the VEGF exon 3. Cor-
rect targeting was further confirmed by EcoRV digestion and using
a 1-kb HindIII probe in the 39 UTR. Three independent clones (G3,
D10, and F6) were aggregated with CD-1 morulae as described
previously (Pirity et al., 1998). All analyses described further were
performed on CD-1/129 hybrid background.
Genotyping of Progeny
To identify mice carrying the targeted allele PCR analysis was
performed on ear punches or yolk sac samples. Oligonucleotides
used here, VEGF-WT, 59-ATGTGACAAGCCAAGGCGGTG-39,
and VEGF-exon8, 59-TGGCGATTTAGCAGCCAGATA-39, giving
a 300-bp band, identified the wild-type allele. To distinguish the
two targeted alleles, different primers were used: Neo, 59-
CACATACACTTCATTCTCAG-39, VEGF-exon8, amplifying a
85-bp band corresponding to the VEGFLacZ; and LacZ59, 59-
GGTAGGGGTTTTTCACAGAC-39, and VEGF-exon8, amplifying
a 450-bp band for VEGFLacZDneo.
b-Galactosidase Staining of Embryos
Embryos were dissected in cold phosphate-buffered saline (PBS)
and subsequently fixed in 0.2% glutaraldehyde, 2% paraformalde-
hyde, 2 mM EGTA, 2 mM MgCl2 in 100 mM Pipes buffer, pH 6.9,
t room temperature for 30–90 min depending on the size of the
mbryos, then washed three times in PBS at room temperature for
0 min each. Staining was performed at 37°C in 0.02% X-Gal, 5
M K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2 in PBS overnight.
The stained embryos were washed, postfixed in 4% paraformalde-
hyde, embedded in paraffin, and sectioned at 5 mm. Sections were
ounted onto glass slides and counterstained with Nuclear Fast
ed.
Later stage embryos (.E10.5) were fixed for 2–4 h at 4°C in 4%
araformaldehyde, washed in PBS, and incubated in 15% and then
0% sucrose at 4°C overnight. Embryos were embedded in Tissue
ek (OCT compound), frozen on dry ice, and cryosectioned be-
ween 10 and 20 mm. Cryosections were washed in PBS and
ncubated overnight at 37°C with the same X-Gal solution as
escribed above. Finally, the sections were washed and counter-
tained with eosin.
RESULTS
Generation of a VEGF-LacZ Knock-in Mouse
ModelTo overcome the heterozygous lethality of the VEGF null
mutation, we introduced the sequence encoding the
Copyright © 1999 by Academic Press. All rightb-galactosidase reporter (LacZ cassette) into the noncoding
region of exon 8, 39 of the VEGF stop codon. An IRES
preceded the LacZ coding sequence. Consequently, our
strategy permits the production of two functional proteins
(VEGF and LacZ) from a single bicistronic transcript.
The targeting vector was generated using a 6-kb SmaI
fragment of genomic DNA spanning exons 4 to 8 as the 59
rm of homology and a 4.4-kb SmaI fragment of sequence
ncompassing the 39 UTR as the 39 arm of homology (Fig.
A). The IRES-LacZ cassette followed by a loxP-flanked
eomycin resistance cassette, which carried its own pro-
oter (PGK) and polyadenylation site (also from PGK), was
ntroduced into exon 8 after the VEGF stop codon (Fig. 1A).
After electroporation of ES cells, targeted clones were
elected for neomycin resistance and homologous recombi-
ation events were identified by Southern blot analysis,
ith a targeting frequency of approximately 25%. Three
ndependent targeted ES cell lines were used to generate
himeric mice by ES cell 7 embryo aggregation, which all
ransmitted the targeted allele (VEGF-LacZ-KI) through
heir germ line (Fig. 1B, lane 1/KI). In order to minimize
nterference, the PGK-neo cassette was deleted by crossing
he VEGF-LacZ-KI heterozygous mice with CMV-Cre trans-
enic mice (Nagy et al., 1998), generating the VEGF-LacZ
I-Dneo heterozygous mutant mice. The excision was de-
ected by PCR (data not shown) and confirmed by Southern
lot analysis (Fig. 1B, lane 1/KIDneo). All lines gave iden-
ical LacZ staining, so all data were pooled.
VEGF in Early Implantation
VEGF was first detected through LacZ staining at embry-
onic day E4.0 in the primitive endoderm of the blastocyst
(Figs. 2B and 2C). LacZ staining was not detectable in E3.5
blastocysts (Fig. 2A). Prior to gastrulation at E5.5, LacZ was
strongly expressed in the extraembryonic visceral and pari-
etal endoderm (Fig. 2D). A lower level of expression was
observed in the extraembryonic ectoderm but this signal as
well as the signal in the extraembryonic parietal endoderm
decreased after cavitation by E6.0 (Fig. 2E). The ectoplacen-
tal cone and the chorion, which derived from the extraem-
bryonic ectoderm, were completely negative at E7.5 (Fig.
2G). The only trophectoderm-derived cells expressing LacZ
from the VEGF locus are the primary giant cells invading
the maternal decidua (arrowheads in Fig. 2D).
During the process of yolk sac vasculogenesis, there is
proliferation of mesodermal cells called hemangioblasts.
These cells give rise to the angioblasts, the precursors of
endothelial cells, and to the precursors of hematopoietic
cells (Risau and Flamme, 1995). These two cell popula-
tions form the first blood islands at around E7.0 –E7.5. At
this stage, VEGF is strongly expressed in the extraembry-
onic compartment of the embryo (Fig. 2F), but not in the
embryo proper. Sections of these embryos show that LacZ
expression from the VEGF locus is abundant in the
extraembryonic visceral endoderm, cells characterized by
s of reproduction in any form reserved.
310 Miquerol et al.FIG. 1. VEGF-LacZ knock-in strategy and germline transmission analysis. (A) Partial restriction maps of the targeting construct, the
mouse VEGF genomic fragment (WT), and the predicted structure of the targeted VEGF alleles (VEGF-LacZ-KI and VEGF-LacZ-KIDneo).
Solid rectangles represent translated exons (exon 1 to 8) and hatched boxes correspond to the untranslated regions of exons 1 and 8. The
IRES-LacZ cassette was inserted into the 39 UTR of the VEGF exon 8, followed by the selectable marker PGK-neo placed between two loxP
sites, indicated by arrows. The VEGF KIDneo allele illustrates the structure of the mutant allele after the removal of the selectable marker
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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311A VEGF LacZ Knock-in Reveals Its Pleiotropic Activitiesa cuboidal, or columnar, shape with large numbers of
vacuoles. In contrast, only a few cells of the visceral
endoderm at the embryonic pole exhibit a low level of
reporter expression (Fig. 2G). b-Galactosidase expression
PGK-neo by the Cre recombinase. Restriction enzymes are indicate
elow the wild-type allele by small horizontal lines. (B) Southern b
sing either BglII or EcoRV, and hybridized with the VEGF exon 3
FIG. 2. VEGF expression during early embryogenesis in the extra
or sections of LacZ-stained embryos (D, E, G, H, I). Embryonic stag
Abbreviations: PEn, primitive endoderm; XEc, extraembryonic ect
extraembryonic visceral endoderm; EEc, embryonic ectoderm; X, ex
ectoplacental cone; Ch, chorion; XMe, extraembryonic mesoderm
blood islands; Bl, primary blood cells; EC, endothelial cells. Arrowh
H, I) 25 mm, (G) 50 mm.ndicated in kilobases (Kb) on the right side of each blot. 1/1represent
1/KIDneo, heterozygous animals after Cre excision VEGF-LacZ-KIDneo
Copyright © 1999 by Academic Press. All rights also seen in the cells derived from extraembryonic
esoderm that form the inner layer of the yolk sac, while
he adjacent hemangioblasts show no expression (Fig.
G). The distribution of labeled cells in the allantois is
follows: E, EcoRV, and B, BglII. VEGF probes I and II are indicated
nalyses of mouse progeny. DNA was isolated from tails, digested
e I) or exon 8 (probe II) probes. The sizes of the predicted bands are
yonic tissues. LacZ staining of whole-mount embryos (A, B, C, F)
) E3.5, (B) E4.0, (C) E4.5, (D) E5.5, (E) E6.5, (F, G) E7.5, (H, I) E8.0.
; XEn, extraembryonic endoderm; V, visceral; P, parietal; XVEn,
bryonic part of the embryo; E, embryonic part of the embryo; EPC,
allantois; Hem, hemangioblasts; EEn, embryonic endoderm; BIs,
in the panel D indicate the trophoblast giant cells. Size bar: (D, E,d as
lot a
(probembr
es: (A
oderm
traem
; Al,s wild-type animal DNA; 1/KI, heterozygous VEGF-LacZ-KI; and
.
s of reproduction in any form reserved.
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312 Miquerol et al.sparse and the nonexpressing cells may in fact represent
the angioblast population (Fig. 2H). By day E8.0 the yolk
sac vasculature is formed by fusion of blood islands.
LacZ/VEGF expression is maintained in the extraembry-
onic visceral endoderm and extraembryonic mesoderm of
FIG. 3. VEGF and flk-1 gene expression during embryonic va
eterozygous embryos (A, B, C) and VEGF KI (D, E, F). Sections
mbryonic stages: (A, D, G) E8.0, (B, E, H) E8.5, and (C, F, I) E9.0. Ab
ut, HT, heart. Arrows in A, B, D, and E represent the dorsal aortathe yolk sac, whereas the endothelium and primary blood
cells are negative (Fig. 2I).
Copyright © 1999 by Academic Press. All rightVEGF in the Embryo between Day E8.0
and Day E9.0
Vascularization of the embryo proper begins between
E8.0 and E9.0 (Figs. 3D–3I). The first LacZ/VEGF-positive
ature development. Whole-mount LacZ staining of Flk-1/LacZ
EGF KI LacZ stained embryos are presented in the G, H, and I.
iations: FG, foregut; HM, head mesenchyme; NT, neural tube; GT,
is. Size bar: (G) 25 mm, (H) 50 mm, (I) 100 mm.scul
of Vcells appear at day E8.0 in the definitive endoderm of the
embryo, which forms the foregut pocket and the hindgut
s of reproduction in any form reserved.
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313A VEGF LacZ Knock-in Reveals Its Pleiotropic Activitiesdiverticulum (Figs. 3D and 3G). At this stage, the dorsal
aorta is formed by vasculogenesis in close apposition to the
embryonic endoderm; it is even more visible from the
lateral view of the embryo (Fig. 3A) (Coffin and Poole, 1988).
To visualize endothelial cells at this developmental stage
we took advantage of a flk-1-targeted allele mouse line
carrying a LacZ reporter gene introduced into the flk-1
locus (Shalaby et al., 1995).
At day E8.5 the primitive gut, heart, and headfolds are all
ositive for LacZ/VEGF expression (Fig. 3E). Sections show
trong expression in the endoderm (gut epithelium),
hereas expression is moderate in mesodermal derived
issues such as the heart (myocardium and endocardium)
nd the cephalic mesenchyme (Fig. 3H). The organ distri-
ution of LacZ/VEGF expression correlates with the expan-
ion of endothelial cells in the head mesenchyme and the
eart as shown in Fig. 3B (lateral and frontal views of the
ame embryo) by expression of the LacZ/flk-1 allele.
Beginning from E9.0, LacZ/VEGF is extensively ex-
ressed in the embryo (Fig. 3F), in parallel with its vascu-
arization as is indicated by LacZ/flk-1 expression (Fig. 3C).
otably, the expression of LacZ/VEGF is now also detect-
ble in the neural tube (Fig. 3I).
VEGF in the Heart
Development of the heart is complex and production of a
well-defined four-chamber compartment from a single tube
requires a number of steps, including turning, septation,
and remodeling. The primary heart tube comprises two
layers, the outer myocardium and an inner endocardial
layer, which it surrounds. Both of these are derived from
mesodermal cells which emerge at the base of the headfold.
The future myocardium forms the cardiogenic plate, and
the endocardial cells proliferate subjacent to this structure.
At E8.0, when the cardiogenic plate appears, LacZ/VEGF is
barely detectable in the cardiac precursor cells (Fig. 4A). A
few endocardial cells appear between the cardiogenic plate
and the embryonic endoderm but they do not stain for LacZ
(Fig. 4A). By day E8.5 the myocardium and part of the
endocardium are strongly positive for LacZ staining (Fig.
4B). The endocardium is derived from two cell populations,
mesodermal cells localized in the cardiogenic mesenchyme
in close proximity to the endoderm and mesodermal cells
migrating from the lateral plate and head mesenchyme
(Eisenberg and Markwald, 1995). The formation of the
endocardium by these two precursor populations might
explain the differential expression of LacZ/VEGF observed
in this layer. At day E9.0, LacZ/VEGF-positive endocardial
cells are localized along the entire length of the heart tube,
in the ventral aorta, in the aortic sac, in the bulbus cordis,
and in the sinus venosus (Fig. 4C). By E9.5, LacZ/VEGF
expression in endocardial cells becomes restricted to the
outflow tract and the atrioventricular canal (Figs. 4D–4F).
Endocardial cells lining the aortic sac as well as those that
are lining the cushions show strong expression of LacZ/
Copyright © 1999 by Academic Press. All rightEGF, whereas the endocardial cells that have undergone
esenchymal transition to form the cushion are negative
Fig. 4G). The shape of these LacZ-positive cells is round
ompared to the elongated shape of endothelial cells
resent in the yolk sac or the ventricle. LacZ/VEGF-
xpressing endocardial cells are located at the cushion
orders of the truncus arteriosis (Fig. 4H) and in the atrio-
entricular canal (Fig. 4I). After the formation of the cush-
ons and valves, LacZ/VEGF is no longer expressed in these
ells but persists in the cardiac outflow tract (Fig. 4K). The
ndocardium of the ventricle, atrium, and even the sinus
enosis is now completely negative for LacZ staining. The
ite of emergence of the aorta from the heart is the only
ocation where LacZ/VEGF is detectable in vascular endo-
helium. Expression in the aorta declines with increasing
istance from the heart. In the myocardium, compact and
rabecular layers express LacZ/VEGF, and there was a
igher level of expression in the septum transversum sur-
ounding the atrioventricular canal (Figs. 4F and 4I).
At E14.5, there was very strong LacZ staining in the
entricles and a lower level of staining in the atria (Fig. 4J).
he compact and trabecular myocardial layers express
acZ/VEGF at a high level and an intense blue staining is
lso observed in the spiral and interventricular septae (Fig.
K). The endocardium and the endocardium-derived cush-
ons do not express LacZ/VEGF, with the exception of the
ndocardial cells lining the outflow tract (Fig. 4K). Interest-
ngly, flk-1 expression at E13.5, visualized by the LacZ
nock-in (Shalaby et al., 1995) allele (LacZ/flk-1), parallels
that of LacZ/VEGF in the heart, being higher in the ven-
tricles than in the atria (Fig. 4L). However, in the ventricles,
its expression is complementary to VEGF since Flk-1-
positive cells are present throughout the endocardium with
the exception of the endocardial cushions (Fig. 4M). In the
entire embryo, the only cell population found to be express-
ing both VEGF and its receptor Flk-1 was the endothelium
lining the outflow tract (Figs. 4K and 4M).
VEGF during Organogenesis
Sections of VEGF LacZ knock-in heterozygous embryos
during the second half of gestation were examined in order
to evaluate the potential role of VEGF during organogen-
esis. In Fig. 5A, whole-mount LacZ staining of a day E14.5
embryo indicates that LacZ/VEGF is widely expressed
throughout the embryo. However, sections revealed that
expression is restricted, with strong staining in particular
organs and no staining in others (Figs. 5B and 5C).
Most organs are vascularized by either vasculogenesis or
angiogenesis. Chimera analyses have shown that in organs
derived from mesoderm and endoderm vascularization oc-
curs primarily through vasculogenesis while organs derived
from ectoderm–mesoderm are vascularized by angiogenesis
(Pardanaud et al., 1989). The levels of VEGF expression
appear to relate to these two mechanisms. In mesoderm- or
endoderm-derived tissues, like the lung and spleen, LacZ/
s of reproduction in any form reserved.
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314 Miquerol et al.VEGF staining is very strong and uniform (Figs. 5H and 5J).
The vasculature of these organs, detected by LacZ/flk-1, is
FIG. 4. VEGF expression during the development of the mouse em
whole-mount LacZ staining of embryonic heart in J. Flk-1 LacZ-st
(A) E8.0, (B) E8.5, (C) E9.0, (D–I) E9.5, (J, K) E14.5, (L, M) E13.5. Abbr
endocardial cells; M, myocardium; AO, ventral aorta; AS, aortic
chamber; ECU, endocardial cushion; TAW, truncus arteriosis wa
transversum; AVC, atrioventricular canal; A, atrium; V, ventricle
00 mm.dense and perfectly complements VEGF-expressing cells
(Figs. 5I and 5K).
v
i
Copyright © 1999 by Academic Press. All rightThe brain is vascularized by angiogenesis. Here, LacZ/
EGF expression is moderate and present mainly in the
nic heart. Sections of VEGF KI LacZ-stained embryos (A–I, K) and
embryos or sections are presented in L and M. Embryonic stages:
ions: NE, neuroepithelium; FG, foregut; CP, cardiogenic plate; EN,
BC, bulbus cordis; SV, sinus venosis; CVC, common ventricular
, truncus arteriosis; CAC, common atrial chamber; ST, septum
spiral septum. Size bar: (A–C, G–I) 25 mm, (D–F) 50 mm, (K, L)bryo
ained
eviat
sac,
ll; TAentral layer of the neuroepithelium (Fig. 5F). Angiogenesis
s very active in this tissue and LacZ/flk-1 staining shows
s of reproduction in any form reserved.
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315A VEGF LacZ Knock-in Reveals Its Pleiotropic Activitiesthat the newly formed blood vessels penetrated the neuro-
epithelium perpendicularly and grew forward towards the
highly VEGF-positive ventral layer (Fig. 5G). In the kidney,
LacZ/VEGF-expressing cells are restricted to the epithe-
lium of the ureteric bud, the surrounding mesenchyme and
the podocytes, with almost no expression in the outer
FIG. 5. VEGF expression during organogenesis at E14.5. VEGF-KI
C, D, F, H, and J. Flk-1 expression from E13.5 Flk-1KO LacZ-stai
plexus; VL, ventral layer of the brain; Pit, pituitary gland; T, tee
primordium; St, stomach; Ts, testis; Sp, spleen; Ad, adrenal gland;
bud. (D–G) Enlargements of embryonic organs at E14.5. (D, E) Kidn
C) 400 mm, (D–F, H–J) 50 mm, (G, K) 25 mm.cortex (Fig. 5D). Vascularization of the kidney proceeds
partially by angiogenesis, and LacZ/flk-1 is highly ex-
Copyright © 1999 by Academic Press. All rightressed in vessels surrounding the ureteric bud and not at
he periphery of the kidney (Fig. 5E).
VEGF Close to Fenestrated Endothelium
During organogenesis, the endothelium undergoes matu-
-stained embryo presented by whole mount in A or sections in B,
mbryo is presented in E, G, I, and K. Abbreviations: CP, choroid
imordium; Ht, heart; L, lung; I, intestine; Mm, mammary gland
idney; IV, intervertebral region; M, medulla; C, cortex; U, ureteric
, G) ventral layer of the brain, (H, I) lung, (J, K) spleen. Size bar: (B,LacZ
ned e
th pr
Kd, kration and specialization to match the needs of each par-
ticular organ function. Microvascular endothelium can be
s of reproduction in any form reserved.
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316 Miquerol et al.subdivided into continuous and discontinuous endothe-
lium. Fenestrated endothelium represents a specialized
subtype of discontinuous endothelium and is characterized
by small pores covered by diaphragms (Bennett et al., 1959;
Risau, 1995). Fenestrated endothelium is found in close
proximity to epithelia that have a functional requirement
for permeable endothelium. Figures 6A–6D show the pat-
tern of expression of VEGF in organs in which fenestrated
endothelium is present. In endocrine glands, like the adre-
nal gland, which sustain a secretory role, LacZ/VEGF is
abundant (Fig. 6A). The same is true for the epithelial cells
of the choroid plexus (Fig. 6B). In the kidney, the glomerular
podocytes play the role of a filtration unit, and LacZ/VEGF
is also present in these cells (Fig. 6C). Fenestrated endothe-
FIG. 6. VEGF expression in developing organs containing fenestra
Flk-1 expression in fenestrated endothelium (E–H). Sections of d
embryos. (A, E) Adrenal gland, (B, F) choroid plexus, (C, G) kidney
dermal papilla; E, epidermal hair bulb), (J) mammary gland (DM,
neurohypophysis; I, pars intermediate; D, pars distalis), (L) tooth
lamina). Size bar: (A–J) 25 mm, (K, L) 50 mm.lium is also described in the gastrointestinal tract in asso-
ciation with its absorptive function and LacZ/VEGF is
Copyright © 1999 by Academic Press. All rightlocalized in the stomach and intestine (Figs. 5B and 6D). In
comparison, LacZ/flk-1 is present in the same tissues with
a high level of expression in all endothelial cells that are
situated in close contact to the different VEGF-positive
epithelium (Figs. 6E–6H).
VEGF during Inductive Tissue Interactions
Inductive tissue interactions constitute a general mecha-
nism that is observed throughout embryonic development.
During organogenesis, secondary inductive events occur
between epithelial and mesenchymal tissues, leading to the
organization of cells into tissues or organs (Gilbert, 1988).
LacZ/VEGF expression was examined during the formation
ndothelium (A–D) or during secondary inductive interactions (I–L).
nt organs of day E14.5 VEGF-KI or E13.5 Flk-1KO LacZ-stained
podocytes; G, glomerula), (D, H) stomach, (I) whisker follicles (P,
e mesenchyme; E, mammary epithelium), (K) pituitary gland (N,
ordium (S, mesenchymal dental sac; P, dental papilla; L, dentalted e
iffere
(PO,
densof organs dependent on secondary induction events and it
was usually spatially restricted in these tissues. For in-
s of reproduction in any form reserved.
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317A VEGF LacZ Knock-in Reveals Its Pleiotropic Activitiesstance, in the whisker follicle, LacZ/VEGF was expressed in
the dermal papilla, which is derived from condensed mes-
enchymal cells developing under the skin surface, but not
in the hair bulb, which arises from epidermal structures
(Fig. 6I). In contrast, during mammary gland development,
LacZ/VEGF was present in the ectoderm-derived epithe-
lium but not in the dense mammary mesenchyme sur-
rounding the embryonic mammary bud (Fig. 6J). The pitu-
itary gland is formed by the interaction of two ectodermal
derivatives, Rathke’s pouch, which is derived from the oral
ectoderm, and a neuroectodermal invagination. At E14.5,
LacZ/VEGF was found in the neurohypophysis and at a
lower level in the pars distalis, which proceed to form the
posterior and the anterior lobes of the hypophysis, respec-
tively (Fig. 6K). The pars intermediate does not express
LacZ/VEGF (Fig. 6K). During tooth development, LacZ/
VEGF is located in the dental lamina, which is derived from
the oral ectoderm, and is especially high in the enamel knot
in the dental epithelium. The neural-crest-derived dental
papilla does not express LacZ/VEGF, whereas the mesen-
chymal dental sac that surrounds the tooth germ does (Fig.
6L). The pattern of expression of LacZ/VEGF during orga-
nogenesis is well-defined, as it is in the early embryo, which
suggests a role for VEGF during the entire process of
embryonic development.
VEGF in the Female Reproductive Tract
To validate the use of this mouse model to study VEGF
expression during physiopathological processes, we looked
at the LacZ/VEGF expression during the vascular remodel-
ing that occurs during the ovarian cycle and embryonic
implantation. VEGF expression during those processes has
already been characterized (Ferrara et al., 1998; Maisonpi-
erre et al., 1997; Shweiki et al., 1993). We confirmed by
acZ staining that VEGF is present in the preovulatory
ollicule before vessel invasion and is first detectable in
ells of the granulosa that surround the oocyte (Figs. 7A–
D). After ovulation, LacZ/VEGF is strongly expressed in
he developing corpus luteum (Figs. 7E–7H). At E7.0–9.0,
hen angiogenesis is occurring in the maternal decidua and
ewly formed blood vessels are converging on the embryo,
EGF and LacZ/VEGF is expressed in these cells (Figs. 7I
nd 7J). Decidual cells express high level of LacZ/VEGF
ith the exception of the deepest layer of the endometrium
Figs. 7K and 7L). The same profile is observed by in situ
ybridization (Shweiki et al., 1993). The myometrium
emains negative for LacZ/VEGF staining (Fig. 7L).
DISCUSSION
The pivotal role that VEGF plays in normal development
and disease has been revealed by gene targeting experiments
(Carmeliet et al., 1996; Ferrara et al., 1996). To understand
the details of this role we have created a new VEGF allele by
p
1
Copyright © 1999 by Academic Press. All rightomologous recombination. This allele allows independent
ranslation of VEGF and LacZ from the same bicistronic
RNA. Not only did this approach yield a convenient LacZ
ag for VEGF expression but it also circumvented the lethal
aploinsufficiency of VEGF. This strategy presents several
dvantages over in situ hybridization. b-Galactosidase ac-
ivity is both easily detectable and very sensitive. More-
ver, reporter activity can be detected at single cell level
hus providing the opportunity to clearly determine the
dentity of the cells expressing VEGF. The IRES element
ranslating LacZ from the 39 UTR of VEGF did not appear to
ompromise VEGF translation from the bicistronic mRNA
roduced. Therefore, the heterozygous mice carrying the
EGF-LacZ KI are viable and provide an invaluable tool for
haracterizing VEGF expression. This resolution gave a
nique opportunity to pinpoint the detailed roles of VEGF
uring development. Some of these have been already
ndicated by experiments describing VEGF expression using
he less sensitive RNA in situ hybridization (Breier et al.,
992; Dumont et al., 1995; Peters et al., 1993).
In this study, we report that embryonic expression of
EGF initiates in the primitive endoderm of E4.0 blasto-
ysts, a time when VEGF mRNA is also detectable by
T-PCR (data not shown). As gastrulation proceeds, a
ommon progenitor to hematopoietic and vascular cells,
alled the hemangioblast, is believed to arise from the
esoderm located at the posterior primitive streak and to
olonize the yolk sac (Dieterlen-Lie`vre, 1998). Mouse em-
ryonic explant experiments recently demonstrated that
ignals from the primitive endoderm are required around
he onset of gastrulation for hematopoietic and vascular
evelopment (Belaoussoff et al., 1998). VEGF expression in
he extraembryonic visceral endoderm of the yolk sac may
rovide the paracrine signal essential for the differentiation
f endothelial cells from angioblasts (Risau and Flamme,
995). In agreement with this suggested role, VEGFR2/Flk-
-deficient embryos failed to produce mature endothelial
ells; however, immature angioblasts were able to form
Shalaby et al., 1995). Confirming previous results of in situ
ybridization (Dumont et al., 1995), LacZ/VEGF is highly
xpressed in the extraembryonic visceral endoderm during
asculogenesis. With our system we were able to extend
hese observations by showing that LacZ expression is also
etectable in the mesodermal component of the yolk sac.
owever, LacZ/VEGF is not detectable in either the blood
slands or the mature endothelial cells of the yolk sac. This
xpression pattern strongly supports the earlier suggestion
hat VEGF may act as a paracrine signal regulating vascu-
ogenesis (Risau and Flamme, 1995), by inducing differen-
iation of the angioblasts and proliferation and migration of
he arising endothelial cells in the yolk sac in order to form
primary vascular network.
It is believed that the endothelial cells of the embryoroper arise from two types of progenitors (Pardanaud et al.,
996). The first type of progenitor is purely angioblastic and
s of reproduction in any form reserved.
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318 Miquerol et al.derives from the somitic mesoderm, whereas the second
type is localized at the paraaortic splanchnopleura and
shares common properties with the yolk sac hemangio-
blasts (Godin et al., 1993; Jaffredo et al., 1998). In the
mbryo proper expression of VEGF begins in an endodermal
ineage since it is strongly expressed in both the foregut and
he hindgut. The dorsal aorta, the first vessel formed in the
mbryo proper, arises by vasculogenesis with the contribu-
ion of both types of precursors (Coffin and Poole, 1988;
oole and Coffin, 1989). This process proceeds in close
roximity to the primitive gut, a region exhibiting high
acZ/VEGF expression. The VEGF knockout has shown
FIG. 7. VEGF expression in the female reproductive tract. (A–H
Preovulatory stages are presented by whole-mount LacZ staining
sections showing a small follicule (C) and a large preovulatory fo
staining of the entire ovary (E) or a detail of a corpus luteum (F). S
luteum ;8 h (G) or ;12 h (H) after ovulation. (I–L) VEGF expressio
taining of decidual tissue of E7.5 (I) and E9.5 (J) embryo. Sections of
all (K, L). Abbreviations: O, oocyte; G, granulosa; CL, corpus lute
uscle layer of the uterine wall. Size bar: (C) 25 mm, (D, G, H, L)hat partial or complete lack of VEGF impairs the formation
f the dorsal aorta (Carmeliet et al., 1996; Ferrara et al.,
e
Copyright © 1999 by Academic Press. All right996). In avian embryos, quail–chick transplantations dem-
nstrate that the endoderm induces angioblastic and hema-
opoietic development (Pardanaud and Dieterlen-Lie`vre,
999). Moreover, this hemangioblastic induction can be
imicked by VEGF and also by bFGF and TGFb. Taken
ogether, these findings suggest that the endodermal com-
artment plays an essential role in the formation of the
orsal aorta by providing VEGF as the paracrine signal for
heir development. This appears to be true across species. In
ebrafish, a signal from the notochord plays an important
ole in the formation of the dorsal aorta, but VEGF local-
zation has not been determined in this organism (Fouquet
GF expression during vascular remodeling in the ovarian cycle.
e entire ovary (A) or a detail of a preovulatory follicule (B) and by
le (D). Postovulatory stages are presented by whole-mount LacZ
ns of this ovary show LacZ/VEGF staining in a developing corpus
the decidua and embryonic implantation site. Whole-mount LacZ
.5 embryo surrounded by the maternal decidua and uterine muscle
E, embryo; D, maternal decidua; U, uterus; EN, endometrium; M,
m, (K) 100 mm.) VE
of th
llicu
ectio
n in
an E7t al., 1997; Sumoy et al., 1997). Similarly, in Xenopus, a
signal from the hypochord is required for the formation of
s of reproduction in any form reserved.
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319A VEGF LacZ Knock-in Reveals Its Pleiotropic Activitiesthe aorta (Cleaver et al., 1997). This structure, absent in
other vertebrates, is induced by the notochord itself and
produces VEGF, which mediates angioblast migration dur-
ing the dorsal aorta formation (Cleaver and Krieg, 1998).
These findings indicate that it is not the embryonic
endoderm per se but rather a factor such as VEGF secreted
by this germ layer that is required for a proper formation of
the dorsal aorta.
At E8.5, LacZ/VEGF is also detectable in the head mes-
enchyme, which contains a second pool of pure angioblasts.
In chick embryos, the angiogenic potential of the cephalic
mesenchyme has been demonstrated by quail/chick trans-
plantations (Couly et al., 1995). This angiogenic potential
could be mimicked by direct contact between mesoderm
and ectoderm or by EGF/TGFb treatments of the mesoderm
Pardanaud and Dieterlen-Lie`vre, 1999). Nevertheless, our
ndings suggest that the angiogenic potential of the head
esenchyme may also be associated with VEGF expression,
hough this expression is relatively low compared to the
xpression observed in the endoderm layers. Angioblasts
ere found in the head mesenchyme of the VEGF and Flk-1
nockout embryos but they were of an immature pheno-
ype and could not form proper vessels (Carmeliet et al.,
996; Shalaby et al., 1995). These results as well as those
btained in avian embryos suggest that VEGF is probably
ot the only factor to induce this angioblastic population,
ut appears to play a role in the differentiation and recruit-
ent of these cells to form an ordered vascular network.
In addition to having a crucial role in establishing embry-
nic vasculature, VEGF may be functionally involved in
rganogenesis. We demonstrate that VEGF is expressed in
he heart, starting at a low level around E8.5 in the
ardiogenic plate and increasing as the heart develops. We
bserved a stronger expression in the ventricles than in the
tria and elevated expression in the septa and trabeculae
ompared to the expression in the compact ventricle wall.
uring cardiac development, the close apposition of two
ell populations, the myocardium and the endocardium,
ppears to be necessary to coordinate the proper develop-
ent of the heart. Endocardial cells arise from the meso-
erm and form a single cell layer between the cardiogenic
late and the endoderm, and it has been shown by explant
ultures that the endoderm plays a role in directing endo-
ardial development (Sugi and Markwald, 1996). VEGF is
resent at a high level in the endodermal cell layer and
ould represent one of the signals responsible for the
evelopment of the endocardium. This hypothesis is sup-
orted by an absence of endocardial cells in the hearts of the
lk-1-deficient embryos (Shalaby et al., 1995). Endocardial/
myocardial interactions are also important for generating
trabeculation in the ventricles (review Fishman and Chien,
1997) and the endocardium is crucial for the formation of
the heart valves and cushions. In vitro studies have sug-
gested that the mesenchymal transition of the endocardium
to form the cushions is under the control of a localized
Copyright © 1999 by Academic Press. All rightmyocardial signal. When we consider these observations in
light of the LacZ/VEGF cardiac expression, we note a high
level of VEGF in the myocardial cells that are in close
contact to the endocardium. This association suggests that
VEGF could be involved in the interaction between endo-
cardium and myocardium. In addition, data demonstrating
that an elevated level of VEGF in the developing heart can
induce heart failure in the mouse (L. Miquerol et al., in
preparation) and in the quail (Feucht et al., 1997) strongly
support this hypothesis.
Targeted disruption of VEGF has demonstrated that the
level of VEGF expression is of major importance for normal
embryonic development. However, because of the early
lethality of the VEGF2/2 and VEGF1/2 embryos, obser-
vations are restricted to stages at which vasculogenesis
predominates. Endoderm/mesoderm-derived tissues that
are believed to be vascularized by vasculogenesis show a
higher and a homogeneous pattern of expression of LacZ/
VEGF compared to ectoderm/mesoderm-derived tissues
vascularized by angiogenic processes. In particular, a high
level of LacZ/VEGF expression is found in the yolk sac and
gut endoderm where vasculogenesis leads to the formation
of blood islands and dorsal aortae, respectively. During
organogenesis, the reporter is highly expressed in spleen
and lung, tissues that are thought to be vascularized by
vasculogenesis (Coffin and Poole, 1988; Pardanaud et al.,
1989). In contrast expression is low in the brain and
neuroectoderm, examples of tissues in which the vascular
plexus is formed by angiogenesis.
Vascularization of the kidney is complex and probably
involves both vasculogenesis and angiogenesis (Abraham-
son et al., 1998). In the kidney, VEGF is expressed at
different levels and in several different types of cells and
suggests to us a correlation between the expression level
and the function. VEGF is expressed in the ureteric bud
epithelium and the surrounding mesenchyme. Similar anal-
yses using LacZ/flk-1 mice revealed that the first Flk-1-
positive cells arise along the ureteric bud (Robert et al.,
1998). The localization of VEGF may serve as a source of
chemoattractant protein for the outside vasculature that
colonized the kidney. Very high VEGF expression is de-
tected in the podocytes, which form the epithelium of the
glomeruli, whereas Flk-1 is localized to the glomerular
endothelium. In the glomeruli, where the endothelium is
fenestrated, this permeable endothelium is always located
in close proximity to the epithelium. Fenestrated endothe-
lium has also been shown to be present in tumors in which
VEGF is induced (Senger et al., 1993). Given its documented
permeability-inducing activity, VEGF appears to be a can-
didate for the induction and the maintenance of the fenes-
trated capillary phenotype (Esser et al., 1998; Risau, 1998).
Our data confirm the complementary expression of VEGF
and flk-1 during embryonic development (Dumont et al.,
1995; Flamme et al., 1995; Millauer et al., 1993). These
genes are exclusively expressed in two different cell types;
s of reproduction in any form reserved.
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320 Miquerol et al.Flk-1 is expressed in the endothelium and VEGF in the
neighboring cells. With the VEGF LacZ-KI model, we have
shown that one subcompartment of the endocardium,
endothelial-like cells, is able to produce both VEGF and
Flk-1. It is worth noting that some of these cells are
predestined to undergo mesenchymal transition in order to
form the cardiac cushions. Thus, these cells do not present
a strict vascular phenotype like the endothelial cells that
line the vasculature and might account for their VEGF
expression in these cells. This is not true for the endothe-
lium, which lines the aorta of the outflow tract and also
expresses VEGF. Thus, VEGF expression is not entirely
excluded from the endothelial cells as was originally as-
sumed (Risau and Flamme, 1995; Shifren et al., 1994). In
quail embryo, VEGF expression is detected in the endothe-
lium of the aorta close to the heart, suggesting a potential
autocrine regulation (Aitkenhead et al., 1998).
In summary, LacZ tagging of the VEGF allele has allowed
recise analysis of the pattern of VEGF expression at a
ellular level. This detailed characterization has revealed
mportant information that strongly suggests multiple
unctions for VEGF during embryonic development. This
odel can provide a convenient readout for VEGF expres-
ion in normal physiological processes as well as in patho-
ogical situations.
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